These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16392155)

  • 1. [Efficient improvement of prognosis after myocardial infarct? Additional aldosterone inhibition is required].
    MMW Fortschr Med; 2005 Dec; 147(48):66-7. PubMed ID: 16392155
    [No Abstract]   [Full Text] [Related]  

  • 2. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
    Aaronson K
    Health News; 2003 May; 9(5):4. PubMed ID: 12739453
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aldosterone receptor blockade after acute myocardial infarction with heart failure].
    Bauersachs J; Ertl G
    Med Klin (Munich); 2006 Jun; 101(6):458-66. PubMed ID: 16767569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aldosterone antagonists for all patients with heart failure?].
    Bauersachs J
    MMW Fortschr Med; 2009 Apr; 151(15):33-5. PubMed ID: 19728679
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heart failure after myocardial infarction. Increased risk, poorer treatment].
    MMW Fortschr Med; 2005 Dec; 147(48):67. PubMed ID: 16389866
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
    van der Horst IC; Voors AA; van Veldhuisen DJ
    Clin Res Cardiol; 2007 Apr; 96(4):193-5. PubMed ID: 17294352
    [No Abstract]   [Full Text] [Related]  

  • 10. Aldosterone blockade after myocardial infarction.
    Hackam DG
    CMAJ; 2003 Sep; 169(5):444. PubMed ID: 12952808
    [No Abstract]   [Full Text] [Related]  

  • 11. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
    MMW Fortschr Med; 2003 Oct; 145(44):42-3. PubMed ID: 14655506
    [No Abstract]   [Full Text] [Related]  

  • 12. [REMINDER Study: myocardial infarct without heart failure: does eplerenone have an advantage?].
    Overbeck P
    MMW Fortschr Med; 2013 Mar; 155 Spec No 1(1):20. PubMed ID: 24260911
    [No Abstract]   [Full Text] [Related]  

  • 13. Eplerenone after myocardial infarction?
    Drug Ther Bull; 2008 Jan; 46(1):1-3. PubMed ID: 18171726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of spironolactone in combination with angiotensin-converting enzyme inhibitors or Angiotensin receptor blockers in patients with proteinuria.
    Kim HY; Bae EH; Ma SK; Kim SW
    Kidney Blood Press Res; 2014; 39(6):573-80. PubMed ID: 25531940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone receptor antagonists in the treatment of heart failure.
    Perkerson KA; Coleman CI; White CM
    Conn Med; 2003 Aug; 67(7):397-400. PubMed ID: 14502862
    [No Abstract]   [Full Text] [Related]  

  • 16. Pfizer launches Inspra for heart failure.
    Cardiovasc J S Afr; 2006; 17(4):220. PubMed ID: 17001435
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrating traditional and emerging treatment options in heart failure.
    Nolan PE
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S14-22. PubMed ID: 15160834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Misdiagnosed emergency: heart failure symptoms after infarct. Rapid aldosterone block can safe the tired heart].
    MMW Fortschr Med; 2008 May; 150(22):48-9. PubMed ID: 18700263
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aldosterone antagonists: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
    Yamamoto T
    Nihon Rinsho; 2007 May; 65 Suppl 5():102-6. PubMed ID: 17571373
    [No Abstract]   [Full Text] [Related]  

  • 20. Review article: eplerenone: an underused medication?
    Abuannadi M; O'Keefe JH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):318-25. PubMed ID: 20876342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.